// App-Quantinova.ai

: A Well‐defined Subgroup of Chronic Thromboembolic Pulmonary Hypertension Patients Are Positive for Antiphospholipid Antibodies

Researchers

Presenter

  • C.-Y. Cheng

Principal Investigators

  • Y. Du

  • X. Jiang

  • G. Denas

  • Y.-P. Zhou

  • T. Wu

  • Y.-X. Zhang

  • Z.-Y. Han

  • V. Pengo

  • Z.-C. Jing

Medical Centers

  • Cardiology Clinic, Thrombosis Centre, Department of Cardiac Thoracic and Vascular Sciences, University of Padua, Padua, Italy

  • Fuwai Hospital & Key Laboratory of Pulmonary Vascular Medicine, State Key Laboratory of Cardiovascular Disease, National Centre for Cardiovascular Diseases, Chinese Academy Medical Sciences & Peking Union Medical College, Beijing, China

  • Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy Medical Sciences & Peking Union Medical College, Anaesthesiology Department, Beijing, China

Locations

  • Italy

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Chronic thromboembolic pulmonary hypertension

  • Venous thrombosis

Biomarkers

  • Immunoglobulin G

  • Lactate

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved